Mark Hamner to Middle Aged
This is a "connection" page, showing publications Mark Hamner has written about Middle Aged.
Connection Strength
0.429
-
Ziprasidone Augmentation of SSRI Antidepressants in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Pilot Study of Augmentation Therapy. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2):153-157.
Score: 0.045
-
Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn Behav Ther. 2018 09; 47(5):351-371.
Score: 0.042
-
A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun; 21(2):89-94.
Score: 0.023
-
Clinical presentations in combat veterans diagnosed with posttraumatic stress disorder. J Clin Psychol. 2003 Mar; 59(3):385-97.
Score: 0.015
-
Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol. 2003 Feb; 23(1):15-20.
Score: 0.015
-
Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003 Jan; 18(1):1-8.
Score: 0.015
-
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 07 12; 328(2):151-161.
Score: 0.014
-
Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry. 2001 Sep; 13(3):141-6.
Score: 0.014
-
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
Score: 0.013
-
Clinical presentations of posttraumatic stress disorder across trauma populations: a comparison of MMPI-2 profiles of combat veterans and adult survivors of child sexual abuse. J Nerv Ment Dis. 2000 Oct; 188(10):708-13.
Score: 0.013
-
Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis. 2000 Apr; 188(4):217-21.
Score: 0.012
-
Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999 Apr 01; 45(7):846-52.
Score: 0.011
-
PTSD and automatic implantable cardioverter defibrillators. Psychosomatics. 1999 Jan-Feb; 40(1):82-5.
Score: 0.011
-
Recurrent psychotic depression associated with GM2 gangliosidosis. Psychosomatics. 1998 Sep-Oct; 39(5):446-8.
Score: 0.011
-
Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder. Int Clin Psychopharmacol. 1998 Sep; 13(5):233-4.
Score: 0.011
-
Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res. 1998 Feb 27; 77(3):175-81.
Score: 0.011
-
A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017 Aug; 234(15):2245-2257.
Score: 0.010
-
Psychotic features and combat-associated PTSD. Depress Anxiety. 1997; 5(1):34-8.
Score: 0.010
-
Buspirone potentiation of antidepressants in the treatment of PTSD. Depress Anxiety. 1997; 5(3):137-9.
Score: 0.010
-
A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
Score: 0.010
-
Plasma dopamine and norepinephrine correlations with psychomotor retardation, anxiety, and depression in non-psychotic depressed patients: a pilot study. Psychiatry Res. 1996 Oct 16; 64(3):209-11.
Score: 0.010
-
Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial. Am J Psychiatry. 2016 Dec 01; 173(12):1205-1212.
Score: 0.009
-
Discontinuation of antidepressant medications before ECT. Convuls Ther. 1996 Jun; 12(2):125-6.
Score: 0.009
-
Patient with progressive dementia and choreaothetoid movements treated with buspirone. J Clin Psychopharmacol. 1996 Jun; 16(3):261-2.
Score: 0.009
-
Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans. J Anxiety Disord. 2015 Dec; 36:78-83.
Score: 0.009
-
Exacerbation of posttraumatic stress disorder symptoms with medical illness. Gen Hosp Psychiatry. 1994 Mar; 16(2):135-7.
Score: 0.008
-
Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety. 1994-1995; 1(5):233-6.
Score: 0.008
-
Obsessive-compulsive symptoms associated with acute intermittent porphyria. Psychosomatics. 1992; 33(3):329-31.
Score: 0.007
-
The relationship between combat-related posttraumatic stress disorder and the 5-HTTLPR/rs25531 polymorphism. Depress Anxiety. 2011 Dec 21; 28(12):1067-73.
Score: 0.007
-
An open-label assessment of aripiprazole in the treatment of PTSD. Psychopharmacol Bull. 2009; 42(1):69-80.
Score: 0.006
-
Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. J Clin Psychiatry. 2006 Oct; 67(10):1522-6.
Score: 0.005
-
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatr Serv. 2006 Aug; 57(8):1094-101.
Score: 0.005
-
Documented combat exposure of US veterans seeking treatment for combat-related post-traumatic stress disorder. Br J Psychiatry. 2005 Jun; 186:467-72; discussion 473-5.
Score: 0.004
-
Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. Gen Hosp Psychiatry. 2005 May-Jun; 27(3):169-79.
Score: 0.004
-
Elderly veterans with combat-related posttraumatic stress disorder in specialty care. J Nerv Ment Dis. 2004 Jan; 192(1):75-9.
Score: 0.004
-
Racial differences in psychotic symptoms among combat veterans with PTSD. Depress Anxiety. 2002; 16(4):157-61.
Score: 0.003
-
Differentiation of depression and PTSD symptoms in combat veterans. Depress Anxiety. 2000; 11(4):175-9.
Score: 0.003
-
A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec; 122(4):386-9.
Score: 0.002